全文获取类型
收费全文 | 3196篇 |
免费 | 212篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 82篇 |
妇产科学 | 24篇 |
基础医学 | 357篇 |
口腔科学 | 108篇 |
临床医学 | 210篇 |
内科学 | 803篇 |
皮肤病学 | 49篇 |
神经病学 | 225篇 |
特种医学 | 136篇 |
外科学 | 730篇 |
综合类 | 9篇 |
预防医学 | 75篇 |
眼科学 | 34篇 |
药学 | 197篇 |
中国医学 | 9篇 |
肿瘤学 | 360篇 |
出版年
2023年 | 67篇 |
2022年 | 109篇 |
2021年 | 189篇 |
2020年 | 91篇 |
2019年 | 127篇 |
2018年 | 145篇 |
2017年 | 112篇 |
2016年 | 118篇 |
2015年 | 128篇 |
2014年 | 142篇 |
2013年 | 154篇 |
2012年 | 254篇 |
2011年 | 259篇 |
2010年 | 117篇 |
2009年 | 90篇 |
2008年 | 171篇 |
2007年 | 152篇 |
2006年 | 151篇 |
2005年 | 125篇 |
2004年 | 103篇 |
2003年 | 115篇 |
2002年 | 97篇 |
2001年 | 16篇 |
2000年 | 41篇 |
1999年 | 38篇 |
1998年 | 24篇 |
1997年 | 26篇 |
1996年 | 18篇 |
1995年 | 17篇 |
1994年 | 13篇 |
1993年 | 17篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 19篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 16篇 |
1985年 | 8篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 8篇 |
1980年 | 7篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1976年 | 4篇 |
1972年 | 6篇 |
1967年 | 3篇 |
1966年 | 5篇 |
排序方式: 共有3432条查询结果,搜索用时 14 毫秒
991.
992.
Yoshiko Ishisaka Nobuyuki Nosaka Yuka Mishima Takahiro Masuda Michio Nagashima Yosuke Tanaka Kouhei Yamamoto Masayuki Yoshida Hidenobu Shigemitsu 《Clinical Case Reports》2021,9(12)
Resource scarcity was concerned in the initial surge of the COVID‐19 pandemic. To open slots for Extracorporeal Membrane Oxygenation (ECMO), we tried ECMO weaning allowing invasive ventilation in a 66‐year‐old male with severe COVID‐19, backfiring as ventilator‐induced lung injury. We will discuss ethical conflict in pandemics in this report. 相似文献
993.
Yasushi Asakura Yoshiko Furukawa Shiro Ishikawa Keiko Asakura Koichiro Sueyoshi Munehisa Sakamoto Shunsuke Takagi Seiji Takatsuki Kazuhiro Oyamada Teruo Okabe Hideo Mitamura Satoshi Ogawa Tomoaki Hinohara 《Catheterization and cardiovascular interventions》1998,44(4):420-422
A 65-year-old man with a restenotic lesion of the mid LAD was scheduled for Wiktor stent placement. The IVUS revealed circumferential severe calcification. Two conventional, non-compliant angioplasty balloons inflated to high pressures failed to achieved sufficient dilatation and both ruptured. At this point, we selected high pressure inflation of the Cutting Balloon. The Cutting Balloon achieved adequate dilation for stenting and proved to be useful in predilating a circumferential, heavily calcified lesion. Cathet. Cardiovasc. Diagn. 44:420–422, 1998. © 1998 Wiley-Liss, Inc. 相似文献
994.
Shunsuke Sato Hironori Tsuzura Yuji Kita Yuji Ikeda Daishi Kabemura Sho Sato Nozomi Amano Noboru Yatagai Ayato Murata Yuji Shimada Takuya Genda 《Internal medicine (Tokyo, Japan)》2021,60(22):3569
Direct-acting antiviral (DAA) therapy carries a potential risk of inducing hepatitis B virus (HBV) reactivation. However, the HBV kinetics during and after DAA therapy in patients co-infected with hepatitis C virus (HCV) and HBV remain unknown. We retrospectively evaluated the HBV kinetics during and after sofosbuvir/ribavirin therapy in four HBV inactive carriers co-infected with HCV. HCV was eradicated in all patients. Changes in HBV-DNA levels during treatment differed among patients. The hepatitis B surface antigen (HBsAg) levels uniformly decreased (mean -0.530 logIU/mL) by the end of treatment and returned to near the baseline in all patients. Sofosbuvir/ribavirin therapy thus demonstrated a suppressive effect on HBsAg. 相似文献
995.
996.
Yoshitaka Imaizumi Masako Iwanaga Kisato Nosaka Kenji Ishitsuka Kenichi Ishizawa Shigeki Ito Masahiro Amano Takashi Ishida Naokuni Uike Atae Utsunomiya Koichi Ohshima Junji Tanaka Yoshiki Tokura Kensei Tobinai Toshiki Watanabe Kaoru Uchimaru Kunihiro Tsukasaki for collaborative Investigators 《Cancer science》2020,111(12):4567
Adult T‐cell leukemia/lymphoma (ATL) is a mature T‐cell neoplasm and is classified into four subtypes (acute, lymphoma, chronic, and smoldering) according to the Shimoyama classification, established in 1991 through several nationwide surveys based on the clinical diversity of patients diagnosed in 1983‐1987 in Japan. Thereafter, no such studies have been conducted. Recently, we conducted a nationwide hospital survey using the method of the 1980s studies, collected baseline data on 996 ATL patients diagnosed in 2010‐2011 from 126 hospitals, and reported their unique epidemiological characteristics. Here, we report the follow‐up results of registered ATL patients with the goal of evaluating current prognoses and treatment modalities as of 2016‐2017. Of 770 evaluable patients, 391 (50.8%) had acute‐type, 192 (24.9%) had lymphoma‐type, 106 (13.8%) had chronic‐type, and 81 (10.5%) had smoldering‐type ATL. The initial therapy regimens used for acute/lymphoma‐type ATL were vincristine, cyclophosphamide, doxorubicin and prednisone, followed by doxorubicin, ranimustine, and prednisone and then by vindesine, etoposide, carboplatin, and prednisone (VCAP‐AMP‐VECP)‐like in 38.5/41.7% and cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)‐like in 14.6/13.7% of patients. Allogeneic hematopoietic stem cell transplantation was used to treat 15.9/10.4% of acute/lymphoma‐type ATL patients. The 4‐year survival rates (the median survival time, days) for acute‐, lymphoma‐, unfavorable chronic‐, favorable chronic‐, and smoldering‐type ATL were 16.8% (252), 19.6% (305), 26.6% (572), 62.1% (1937), and 59.8% (1851), respectively. The 4‐year survival rates for acute‐ and lymphoma‐type ATL improved compared with those reported in 1991, but those for chronic‐ and smoldering‐type ATL were not. Further efforts are warranted to develop more efficient therapeutic strategies to improve the prognosis of ATL in Japan. 相似文献
997.
998.
999.
Short‐ and long‐term evaluation of cognitive functions after electroconvulsive therapy in a Japanese population 下载免费PDF全文
1000.
Ushiroyama T Sakuma K Nosaka S 《Journal of cardiovascular pharmacology and therapeutics》2006,11(2):142-148
The short-term effects of bezafibrate on high-density lipoprotein cholesterol quality and triglyceride-rich lipoprotein metabolism in 186 postmenopausal hypertriglyceridemic women were investigated. Patients were randomized to an untreated group and to bezafibrate (400 mg/d) for 6 months. Fasting lipid concentrations, high-density lipoprotein 2, and high-density lipoprotein 3 levels were measured at baseline and after 3 and 6 months. At 3 months, bezafibrate had significantly decreased mean serum triglycerides and remnant-like particle cholesterol levels (105.7 +/- 43.4 mg/dL and 5.33 +/- 2.1 mg/dL, P < .001, respectively) from baseline values (232.5 +/- 63.9 mg/dL and 9.69 +/- 3.8 mg/dL, respectively). It also maintained lower total cholesterol, low-density lipoprotein cholesterol, triglycerides, and remnant-like particle cholesterol concentrations to 6 months. After 3 months, it significantly increased mean serum high-density lipoprotein cholesterol (55.1 +/- 14.7 vs 64.8 +/- 12.1 mg/dL; P < .0001) and maintained higher high-density lipoprotein cholesterol at 6 months. The high-density lipoprotein 2-high-density lipoprotein 3 ratio was decreased after 3 months of therapy with bezafibrate (2.13 +/- 0.68) from the baseline (2.42 +/- 0.71) (P < .01). 相似文献